Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.85% |
| 2 | Technology | 12.31% |
| 3 | Financials | 12.27% |
| 4 | Industrials | 10.64% |
| 5 | Consumer Staples | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
KT
KT
$9.11B
| $2.16M | ﹤0.01% |
+160,800
| New | +$1.94M |
|
|
JOBS
2177
DELISTED
51job Inc
JOBS
| $2.15M | ﹤0.01% |
+69,200
| New | +$1.98M |
|
2178
iShares MSCI South Korea ETF
EWY
$27.8B
| $2.14M | ﹤0.01% |
40,600
+32,400
| +395% | +$1.57M |
|
2179
RELX
RELX
$60B
| $2.14M | ﹤0.01% |
113,900
+22,000
| +24% | +$387K |
|
|
DD
2180
DELISTED
Du Pont De Nemours E I
DD
| $2.14M | ﹤0.01% |
+33,800
| New | +$2.02M |
|
|
STR
2181
DELISTED
QUESTAR CORP
STR
| $2.14M | ﹤0.01% |
86,200
-617,100
| -88% | -$14.3M |
|
2182
Canadian Natural Resources
CNQ
$98.9B
| $2.14M | ﹤0.01% |
163,208
+116,666
| +251% | +$1.24M |
|
2183
CNB Financial Corp
CCNE
$1.03B
| $2.13M | ﹤0.01% |
121,400
+13,360
| +12% | +$235K |
|
|
INTX
2184
DELISTED
Intersections, Inc.
INTX
| $2.13M | ﹤0.01% |
864,900
+14,400
| +2% | +$36.9K |
|
2185
Ralph Lauren
RL
$23.2B
| $2.12M | ﹤0.01% |
22,000
-118,800
| -84% | -$11.6M |
|
2186
SLB Ltd
SLB
$79.8B
| $2.12M | ﹤0.01% |
28,693
-885,900
| -97% | -$62.3M |
|
2187
PRA Group
PRAA
$776M
| $2.11M | ﹤0.01% |
+71,900
| New | +$2.07M |
|
|
LAYN
2188
DELISTED
Layne Christensen Co
LAYN
| $2.11M | ﹤0.01% |
293,800
+72,400
| +33% | +$423K |
|
|
SFS
2189
DELISTED
Smart & Final Stores, Inc.
SFS
| $2.1M | ﹤0.01% |
129,900
+30,900
| +31% | +$499K |
|
2190
Terreno Realty
TRNO
$7.43B
| $2.1M | ﹤0.01% |
89,500
-68,600
| -43% | -$1.53M |
|
|
PMBC
2191
DELISTED
Pacific Mercantile Bancorp
PMBC
| $2.09M | ﹤0.01% |
298,000
+35,500
| +14% | +$248K |
|
|
EVA
2192
DELISTED
Enviva Inc.
EVA
| $2.08M | ﹤0.01% |
+96,013
| New | +$1.81M |
|
2193
Tandem Diabetes Care
TNDM
$1.58B
| $2.08M | ﹤0.01% |
23,930
+7,500
| +46% | +$656K |
|
|
CTG
2194
DELISTED
Computer Task Group, Inc.
CTG
| $2.08M | ﹤0.01% |
407,232
+119,732
| +42% | +$665K |
|
2195
Inuvo
INUV
$12.9M
| $2.08M | ﹤0.01% |
117,244
+13,002
| +12% | +$279K |
|
2196
Global Partners
GLP
$1.72B
| $2.07M | ﹤0.01% |
153,100
-65,500
| -30% | -$976K |
|
|
ECOM
2197
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $2.06M | ﹤0.01% |
183,100
-150,100
| -45% | -$1.74M |
|
2198
Rocky Brands
RCKY
$356M
| $2.06M | ﹤0.01% |
161,500
-21,368
| -12% | -$244K |
|
|
CNSL
2199
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $2.06M | ﹤0.01% |
79,855
-41,500
| -34% | -$891K |
|
|
NP
2200
DELISTED
Neenah, Inc. Common Stock
NP
| $2.06M | ﹤0.01% |
32,300
-4,400
| -12% | -$262K |
|
Similar funds
Jim Simons's Q1 2016 Portfolio in Review
As of Q1 2016, Jim Simons held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Jim Simons's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Jim Simons added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Jim Simons's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Jim Simons fully exited Apple in Q1 2016, selling an estimated $470M.
- Jim Simons's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Jim Simons opened 498 new positions and closed 403 in Q1 2016.
- Jim Simons's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.